393 related articles for article (PubMed ID: 15235598)
1. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.
Xia H; Mao Q; Eliason SL; Harper SQ; Martins IH; Orr HT; Paulson HL; Yang L; Kotin RM; Davidson BL
Nat Med; 2004 Aug; 10(8):816-20. PubMed ID: 15235598
[TBL] [Abstract][Full Text] [Related]
2. RNAi quashes polyQ.
Caplen NJ
Nat Med; 2004 Aug; 10(8):775-6. PubMed ID: 15286770
[No Abstract] [Full Text] [Related]
3. Intranasal administration of IGF-I improves behavior and Purkinje cell pathology in SCA1 mice.
Vig PJ; Subramony SH; D'Souza DR; Wei J; Lopez ME
Brain Res Bull; 2006 May; 69(5):573-9. PubMed ID: 16647585
[TBL] [Abstract][Full Text] [Related]
4. The ins and outs of a polyglutamine neurodegenerative disease: spinocerebellar ataxia type 1 (SCA1).
Orr HT
Neurobiol Dis; 2000 Jun; 7(3):129-34. PubMed ID: 10860780
[TBL] [Abstract][Full Text] [Related]
5. Reduction of Purkinje cell pathology in SCA1 transgenic mice by p53 deletion.
Shahbazian MD; Orr HT; Zoghbi HY
Neurobiol Dis; 2001 Dec; 8(6):974-81. PubMed ID: 11741393
[TBL] [Abstract][Full Text] [Related]
6. Identification of genes that modify ataxin-1-induced neurodegeneration.
Fernandez-Funez P; Nino-Rosales ML; de Gouyon B; She WC; Luchak JM; Martinez P; Turiegano E; Benito J; Capovilla M; Skinner PJ; McCall A; Canal I; Orr HT; Zoghbi HY; Botas J
Nature; 2000 Nov; 408(6808):101-6. PubMed ID: 11081516
[TBL] [Abstract][Full Text] [Related]
7. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1.
Matilla A; Koshy BT; Cummings CJ; Isobe T; Orr HT; Zoghbi HY
Nature; 1997 Oct; 389(6654):974-8. PubMed ID: 9353121
[TBL] [Abstract][Full Text] [Related]
8. SUMO-1 interacts with mutant ataxin-1 and colocalizes to its aggregates in Purkinje cells of SCA1 transgenic mice.
Kang S; Hong S
Arch Ital Biol; 2010 Dec; 148(4):351-63. PubMed ID: 21308649
[TBL] [Abstract][Full Text] [Related]
9. Polyglutamine-expanded ataxin-7 causes cerebellar dysfunction by inducing transcriptional dysregulation.
Chou AH; Chen CY; Chen SY; Chen WJ; Chen YL; Weng YS; Wang HL
Neurochem Int; 2010 Jan; 56(2):329-39. PubMed ID: 19909779
[TBL] [Abstract][Full Text] [Related]
10. Delayed spinocerebellar ataxia in transgenic mice expressing mutant ubiquitin.
Tsirigotis M; Tang MY; Beyers M; Zhang M; Woulfe J; Gray DA
Neuropathol Appl Neurobiol; 2006 Feb; 32(1):26-39. PubMed ID: 16409551
[TBL] [Abstract][Full Text] [Related]
11. RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1.
Keiser MS; Geoghegan JC; Boudreau RL; Lennox KA; Davidson BL
Neurobiol Dis; 2013 Aug; 56():6-13. PubMed ID: 23583610
[TBL] [Abstract][Full Text] [Related]
12. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals.
Servadio A; Koshy B; Armstrong D; Antalffy B; Orr HT; Zoghbi HY
Nat Genet; 1995 May; 10(1):94-8. PubMed ID: 7647801
[TBL] [Abstract][Full Text] [Related]
13. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human.
Huynh DP; Figueroa K; Hoang N; Pulst SM
Nat Genet; 2000 Sep; 26(1):44-50. PubMed ID: 10973246
[TBL] [Abstract][Full Text] [Related]
14. RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice.
Serra HG; Duvick L; Zu T; Carlson K; Stevens S; Jorgensen N; Lysholm A; Burright E; Zoghbi HY; Clark HB; Andresen JM; Orr HT
Cell; 2006 Nov; 127(4):697-708. PubMed ID: 17110330
[TBL] [Abstract][Full Text] [Related]
15. Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes.
Bowman AB; Lam YC; Jafar-Nejad P; Chen HK; Richman R; Samaco RC; Fryer JD; Kahle JJ; Orr HT; Zoghbi HY
Nat Genet; 2007 Mar; 39(3):373-9. PubMed ID: 17322884
[TBL] [Abstract][Full Text] [Related]
16. Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy.
Vig PJ; Hearst S; Shao Q; Lopez ME; Murphy HA; Safaya E
Cerebellum; 2011 Jun; 10(2):254-66. PubMed ID: 21384195
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitous expression of human SCA2 gene under the regulation of the SCA2 self promoter cause specific Purkinje cell degeneration in transgenic mice.
Aguiar J; Fernández J; Aguilar A; Mendoza Y; Vázquez M; Suárez J; Berlanga J; Cruz S; Guillén G; Herrera L; Velázquez L; Santos N; Merino N
Neurosci Lett; 2006 Jan; 392(3):202-6. PubMed ID: 16203087
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of HGF attenuates the degeneration of Purkinje cells and Bergmann glia in a knockin mouse model of spinocerebellar ataxia type 7.
Noma S; Ohya-Shimada W; Kanai M; Ueda K; Nakamura T; Funakoshi H
Neurosci Res; 2012 Jun; 73(2):115-21. PubMed ID: 22426494
[TBL] [Abstract][Full Text] [Related]
19. RNA association and nucleocytoplasmic shuttling by ataxin-1.
Irwin S; Vandelft M; Pinchev D; Howell JL; Graczyk J; Orr HT; Truant R
J Cell Sci; 2005 Jan; 118(Pt 1):233-42. PubMed ID: 15615787
[TBL] [Abstract][Full Text] [Related]
20. Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy.
Keiser MS; Boudreau RL; Davidson BL
Mol Ther; 2014 Mar; 22(3):588-595. PubMed ID: 24419082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
